"Delayed-Action Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dosage forms of a drug that act over a period of time by controlled-release processes or technology.
- Controlled-Release Preparations
- Controlled Release Preparations
- Controlled-Release Preparation
- Controlled-Release Formulations
- Controlled Release Formulations
- Controlled-Release Formulation
- Sustained-Release Preparations
- Sustained-Release Preparation
- Extended Release Preparations
- Extended Release Preparation
- Slow Release Formulation
- Sustained Release Formulations
- Sustained Release Formulation
- Extended Release Formulations
- Extended Release Formulation
Below are MeSH descriptors whose meaning is more general than "Delayed-Action Preparations".
Below are MeSH descriptors whose meaning is more specific than "Delayed-Action Preparations".
This graph shows the total number of publications written about "Delayed-Action Preparations" by people in this website by year, and whether "Delayed-Action Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.
Naeem S, Barkat K, Shabbir M, Khalid I, Anjum I, Shamshad N, Mehmood Y, Khan DH, Badshah SF, Syed MA, Afzal S, Abdullah Z. Fabrication of pH responsive hydrogel blends of chondroitin sulfate/pluronic F-127 for the controlled release of ketorolac: its characterization and acute oral toxicity study. Drug Dev Ind Pharm. 2022 Nov; 48(11):611-622.
Han JR, Wang Q, Yi LX, Li P, Gu Q, Xiao H, Zhu BW, Wu HT. Improving the in vitro and in vivo bioavailability of pterostilbene using Yesso scallop gonad protein isolates-epigallocatechin gallate (EGCG) conjugate-based emulsions: effects of carrier oil. Food Funct. 2022 Sep 22; 13(18):9544-9558.
Mohammadi K, Sani MA, Azizi-Lalabadi M, McClements DJ. Recent progress in the application of plant-based colloidal drug delivery systems in the pharmaceutical sciences. Adv Colloid Interface Sci. 2022 Sep; 307:102734.
Razzaq S, Syed MA, Irfan M, Khan I, Sarfraz RM, Shakir R, Ali S, Iqbal Z, Niaz Y, Mujtaba SH, Raza SA, Raza S, Hanif S. Optimization of metronidazole SR buccal tablet for gingivitis using genetic algorithm. Pak J Pharm Sci. 2021 Nov; 34(6):2149-2158.
Wang LS, Gopalakrishnan S, Luther DC, Rotello VM. Protein-Based Films as Antifouling and Drug-Eluting Antimicrobial Coatings for Medical Implants. ACS Appl Mater Interfaces. 2021 Oct 13; 13(40):48301-48307.
O'Sullivan DL, Byatt N, Dossett EC. Long-Acting Injectable Antipsychotic Medications in Pregnancy: A Review. J Acad Consult Liaison Psychiatry. 2022 Jan-Feb; 63(1):53-60.
Shirk SD, Ameral V, Kraus SW, Houchins J, Kelly M, Pugh K, Reilly E, Desai N. Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A?Retrospective Chart Review. J Dual Diagn. 2021 Jul-Sep; 17(3):207-215.
Sharma M, Bhat R, Usmani Z, McClements DJ, Shukla P, Raghavendra VB, Gupta VK. Bio-Based Formulations for Sustainable Applications in Agri-Food-Pharma. Biomolecules. 2021 05 20; 11(5).
Chaudhuri S, Fowler MJ, Baker C, Stopka SA, Regan MS, Sablatura L, Broughton CW, Knight BE, Stabenfeldt SE, Agar NYR, Sirianni RW. ?-Cyclodextrin-poly (?-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors. ACS Appl Mater Interfaces. 2021 May 12; 13(18):20960-20973.
Reinstein SA, Cosgrove J, Malekshahi T, Deligiannidis KM. Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. J Clin Psychiatry. 2020 11 24; 81(6).